Sodium intake and multiple sclerosis activity and progression in BENEFIT

Autor: Fitzgerald, Kathryn C., Munger, Kassandra L., Hartung, Hans peter, Freedman, Mark S., Montalbã¡n, Xavier, Edan, Gilles, Wicklein, Eva maria, Radue, Ernst wilhelm, Kappos, Ludwig, Pohl, Christoph, Ascherio, Alberto, Strasser fuchs, S., Berger, T., Vass, K., Sindic, C., Dubois, B., Dive, D., Debruyne, J., Metz, L., Rice, G., Duquette, P., Lapierre, Y., Freedman, M., Traboulsee, A., O'Connor, P., Å touraä, P., Talab, R., Zapletalova, O., Kovaå™ova, I., Medova, E., Fiedler, J., Frederiksen, J., Brochet, B., Moreau, T., Vermersch, P., Pelletier, J., Edan, G., Clanet, M., Clavelou, P., Lebrun frenay, C., Gout, O., Kallela, M., Pirttila, T., Ruutiainen, J., Koivisto, K., Reunanen, M., Elovaara, I., Villringer, A., Altenkirch, H., Wessel, K., Hartung, H. . P., Steinke, W., Kã¶lmel, H., Oschmann, P., Diem, R., Dressel, A., Hoffmann, F., Baum, K., Jung, S., Petereit, H., Reske, D., Sailer, M., Kohler, J., Sommer, N., Hohlfeld, R., Henn, K. . H., Tumani, H., Gold, R., Rieckmann, P., Komoly, R., Gacs, G., Jakab, G., Csiba, L., Vecsei, L., Miller, A., Karussis, D., Chapman, J., Ghezzi, A., Gallo, P., Cosi, V., Durelli, L., Anten, B., Visser, L., Myhr, K. . M., Szczudlik, A., Selmaj, K., Stelmasiak, Z., Podemski, R., Maciejek, Z., Cunha, L., Sega jazbec, S., Montalban, X., Arbizu, T., Saiz, A., Barcena, J., Arroyo, R., Fernandez, O., Izquierdo, G., Casanova, B., Lycke, J., Kappos, L., Mattle, H., Beer, K., Coleman, R., Chataway, J., Riordan, J. O., Howell, S., COMI, GIANCARLO

Objective: To assess whether a high-salt diet, as measured by urinary sodium concentration, is associated with faster conversion from clinically isolated syndrome (CIS) to multiple sclerosis (MS) and MS activity and disability. Methods: BENEFIT was a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_____10495::868859a433f78d5befd6c2b5551839ca
Wiley Online Library

Quality of life, depression and fatigue in mildly disabled patients with relapsing–remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study

Autor: Patti, F., Lo Fermo, S., Maimone, D., Messina, S., D'Amico, E., Cimino, V., Gasperini, C., Galgani, S., Orefice, V., Brescia Morra, V., Florio, C., Amato, M., Goretti, B., Portaccio, E., Zipoli, V., Bertolotto, A., Bramanti, P., Sessa, E., Centonze, D., Cottone, S., Salemi, G., Falcini, M., Gallo, P., Perini, P., Gigli, G., Giuliani, G., Pucci, S., Grimaldi, L., Murri, L., Lugaresi, A., Monaco, F., Montanari, E., Motti, L., Neri, S., Paciello, M., Provinciali, L., Ragno, M., Rosati, G., Ruggieri, S., Bell'Antonio, P., Tola, M., Caniatti, L., Tonali, P., Batocchi, A., Trojano, M., Di Monte, E., De Caro, M., Ghezzi, A., Zaffaroni, M., Zolo, P., Zorzon, M., Signorino, M., Scarpini, E., Durelli, L., Carolei, A., Todaro, M., Todaro, R., Spitaleri, D., Tartaglione, A.

Publikováno v: Multiple Sclerosis Journal. 17:991-1001

Background: The precise relationships among quality of life, depression, fatigue and cognitive impairment in multiple sclerosis (MS) are complex and poorly understood. Objective: To assess the effects of subcutaneous interferon beta-1a on quality of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::838886f344d21dce168b2bb9f8547a89
https://doi.org/10.1177/1352458511401943

How to treat patients after natalizumab discontinuation: the TY-STOP 2 study, an Italian, prospective and multicenter study

Autor: Clerico, M., Signori, A., Mercanti, S., Artusi, C. A., Maniscalco, G. T., Antonio Carotenuto, Lanzillo, R., Esposito, S., Capuano, R., Bonavita, S., Lorefice, L., Cocco, E., Annovazzi, P., Baroncini, D., Zaffaroni, M., Vercellino, M., Trebini, C., Cavalla, P., Clerici, V. Torri, Bardina, V., Rolla, S., Durelli, L., Sormani, M. P.

Publikováno v: Web of Science

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::2764ffeb2a85edfccfe995e3e3c4507a
http://hdl.handle.net/2318/1757499

Six year prospective immunological study of alemtuzumab treated patients: identification of markers of the clinical response

Autor: Durelli, L, Rolla, S, De Mercanti, S, Bardina, V, Cucci, A, Taverna, D, Novelli, F, Cocco, E, Vladic, A, Habek, M, Adamec, I, Annovazzi, P, Horakova, D, Clerico, M

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______970::bbcec49c6602607c56e237e3ef00130a
http://hdl.handle.net/2318/1757497

Different clinical, electrophysiological and immunological features of CIDP associated with paraproteinaemia.

Autor: Cocito, D.¹ dariococito@yahoo.it, Durelli, L.², Isoardo, G.²

Publikováno v: Acta Neurologica Scandinavica. Oct2003, Vol. 108 Issue 4, p274. 7p.